|
Market Closed -
Nasdaq
21:00:00 12/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 90.80 USD | +1.42% |
|
+4.44% | +36.81% |
| 08-04 | Argus Adjusts Price Target on DexCom to $96 From $86, Maintains Buy Rating | MT |
| 08-03 | UBS Adjusts Price Target on DexCom to $102 From $96, Maintains Buy Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Medical Equipment, Supplies & Distribution
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 33.79B | |||||
| 190B | |||||
| 116B | |||||
| 63.71B | |||||
| 55.13B | |||||
| 49.41B |
- Stock Market
- Stocks
- DXCM Stock
- Charts DexCom, Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
